Strs Ohio purchased a new position in HealthEquity, Inc. (NASDAQ:HQY – Free Report) in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 11,300 shares of the company’s stock, valued at approximately $999,000.
Other large investors also recently bought and sold shares of the company. Versant Capital Management Inc acquired a new position in HealthEquity in the 1st quarter worth about $28,000. WPG Advisers LLC acquired a new position in HealthEquity in the 1st quarter worth about $28,000. Northwestern Mutual Wealth Management Co. raised its holdings in HealthEquity by 176.4% in the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 655 shares of the company’s stock worth $58,000 after purchasing an additional 418 shares during the period. Larson Financial Group LLC raised its holdings in HealthEquity by 1,366.0% in the 1st quarter. Larson Financial Group LLC now owns 689 shares of the company’s stock worth $61,000 after purchasing an additional 642 shares during the period. Finally, BI Asset Management Fondsmaeglerselskab A S acquired a new position in HealthEquity in the 1st quarter worth about $65,000. Institutional investors and hedge funds own 99.55% of the company’s stock.
HealthEquity Trading Up 3.6%
Shares of HealthEquity stock opened at $95.59 on Friday. The firm has a market capitalization of $8.24 billion, a price-to-earnings ratio of 57.93, a PEG ratio of 1.32 and a beta of 0.50. HealthEquity, Inc. has a fifty-two week low of $74.07 and a fifty-two week high of $116.65. The company has a debt-to-equity ratio of 0.47, a quick ratio of 4.23 and a current ratio of 4.23. The stock has a 50 day moving average of $92.86 and a 200 day moving average of $94.12.
Insider Buying and Selling
Analysts Set New Price Targets
A number of equities analysts recently weighed in on HQY shares. Bank of America upped their price target on HealthEquity from $110.00 to $125.00 and gave the stock a “buy” rating in a report on Wednesday, June 4th. Raymond James Financial reaffirmed a “strong-buy” rating and issued a $120.00 price target (up previously from $115.00) on shares of HealthEquity in a report on Tuesday, July 8th. The Goldman Sachs Group boosted their price objective on HealthEquity from $94.00 to $104.00 and gave the stock a “neutral” rating in a research note on Wednesday, June 4th. Royal Bank Of Canada boosted their price objective on HealthEquity from $109.00 to $110.00 and gave the stock an “outperform” rating in a research note on Wednesday, September 3rd. Finally, Jefferies Financial Group boosted their price objective on HealthEquity from $130.00 to $134.00 and gave the stock a “buy” rating in a research note on Wednesday, September 3rd. One investment analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, HealthEquity presently has a consensus rating of “Buy” and an average price target of $119.77.
Get Our Latest Stock Analysis on HealthEquity
HealthEquity Company Profile
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Read More
- Five stocks we like better than HealthEquity
- What is a Stock Market Index and How Do You Use Them?
- Why Seagate Is Wall Street’s New Favorite AI Infrastructure Play
- The Significance of Brokerage Rankings in Stock Selection
- 3 AI Infrastructure Stocks With Upside After the Summer Rally
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Can Advantage2 Help Overcome D-Wave’s Share Price Plateau?
Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY – Free Report).
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.